[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"leiomyoma-uterine-fibroids\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:leiomyoma-uterine-fibroids":27},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":30,"overallStatus":36,"whyStopped":4,"lastUpdateSubmitDate":37,"lastUpdatePostDateStruct":38,"startDateStruct":41,"completionDateStruct":42,"leadSponsor":44,"locationsCount":5},"100626142","the-effect-of-uterine-manipulator-use-during-abdominal-hysterectomy-on-postoperative-sexual-function-100626142",false,"NCT07431788","The Effect of Uterine Manipulator Use During Abdominal Hysterectomy on Postoperative Sexual Function","A Prospective Randomized Controlled Trial Evaluating the Impact of Uterine Manipulator Use During Total Abdominal Hysterectomy on Postoperative Female Sexual Function","UMAH","Inclusion Criteria:\n\n* Women aged ≥18 years\n* Planned total abdominal hysterectomy for benign indications\n* Sexually active within the last 4 weeks\n* Able to complete the Female Sexual Function Index (FSFI) questionnaire\n* Provided written informed consent\n\nExclusion Criteria:\n\n* Gynecologic malignancy\n* Major additional pelvic reconstructive surgery\n* Severe psychiatric or neurologic disorder\n* Inability to complete follow-up assessments","FEMALE","18 Years",{"count":20,"type":21},60,"ESTIMATED","INTERVENTIONAL",[24],"NA","This prospective, single-center, randomized controlled trial aims to evaluate the effect of uterine manipulator use during total abdominal hysterectomy on postoperative female sexual function at 3 months, assessed by the Female Sexual Function Index (FSFI). Secondary outcomes include operative time, perioperative hemoglobin change, postoperative pain (VAS), hospital stay duration, and 30-day complications.",[27,28,29],"Leiomyoma (Uterine Fibroids)","Adenomyoma of Uterus","Uterine Bleeding",[31,32,33,34,35],"Hysterectomy","Uterin Manipulator","Female Sexual Function","FSFI","Randomized Controlled Trial","RECRUITING","2026-03-02",{"date":39,"type":40},"2026-03-03","ACTUAL",{"date":37,"type":40},{"date":43,"type":21},"2027-02",{"name":45,"class":46},"Erkan Gol","OTHER_GOV"]